2.37
price up icon4.87%   0.11
after-market Handel nachbörslich: 2.32 -0.05 -2.11%
loading

Mangoceuticals Inc Aktie (MGRX) Neueste Nachrichten

pulisher
01:51 AM

Head-To-Head Contrast: Mangoceuticals (MGRX) & The Competition - Defense World

01:51 AM
pulisher
Nov 04, 2024

Mangoceuticals (MGRX) versus The Competition Head to Head Survey - Defense World

Nov 04, 2024
pulisher
Nov 03, 2024

Reviewing Mangoceuticals (MGRX) & Its Rivals - Defense World

Nov 03, 2024
pulisher
Nov 03, 2024

Mangoceuticals (NASDAQ:MGRX) Regains Compliance with Nasdaq Minimum Bid Price Requirement - Defense World

Nov 03, 2024
pulisher
Nov 03, 2024

Head to Head Analysis: Mangoceuticals (NASDAQ:MGRX) & NewGenIvf Group (NASDAQ:NIVF) - Defense World

Nov 03, 2024
pulisher
Nov 02, 2024

Head to Head Review: Mangoceuticals (MGRX) & Its Rivals - Defense World

Nov 02, 2024
pulisher
Nov 01, 2024

Financial Analysis: Mangoceuticals (MGRX) vs. Its Peers - Defense World

Nov 01, 2024
pulisher
Oct 31, 2024

Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewswire

Oct 31, 2024
pulisher
Oct 31, 2024

Mangoceuticals regains full compliance with Nasdaq min bid price requirement - TipRanks

Oct 31, 2024
pulisher
Oct 31, 2024

Analyzing Mangoceuticals (MGRX) and Its Competitors - Defense World

Oct 31, 2024
pulisher
Oct 31, 2024

Mangoceuticals (MGRX) and Its Peers Financial Comparison - Defense World

Oct 31, 2024
pulisher
Oct 31, 2024

Reviewing Mangoceuticals (MGRX) & Its Competitors - Defense World

Oct 31, 2024
pulisher
Oct 31, 2024

Head-To-Head Contrast: Mangoceuticals (MGRX) & Its Peers - Defense World

Oct 31, 2024
pulisher
Oct 29, 2024

Head to Head Analysis: Mangoceuticals (MGRX) vs. Its Competitors - Defense World

Oct 29, 2024
pulisher
Oct 28, 2024

Financial Review: Mangoceuticals (MGRX) & Its Peers - Defense World

Oct 28, 2024
pulisher
Oct 26, 2024

Comparing Mangoceuticals (MGRX) and Its Peers - Defense World

Oct 26, 2024
pulisher
Oct 26, 2024

Mangoceuticals issues shares, raises $78,787 in capital By Investing.com - Investing.com South Africa

Oct 26, 2024
pulisher
Oct 26, 2024

Head to Head Analysis: Mangoceuticals (NASDAQ:MGRX) vs. NewGenIvf Group (NASDAQ:NIVF) - Defense World

Oct 26, 2024
pulisher
Oct 25, 2024

Mangoceuticals issues shares, raises $78,787 in capital - Investing.com India

Oct 25, 2024
pulisher
Oct 25, 2024

Reviewing Mangoceuticals (MGRX) & The Competition - Defense World

Oct 25, 2024
pulisher
Oct 24, 2024

Mangoceuticals (MGRX) & Its Rivals Critical Comparison - Defense World

Oct 24, 2024
pulisher
Oct 24, 2024

Comparing Mangoceuticals (MGRX) & Its Rivals - Defense World

Oct 24, 2024
pulisher
Oct 23, 2024

Mangoceuticals Responds to Claims Made by Eli Lilly in Recent Press Release - Defense World

Oct 23, 2024
pulisher
Oct 23, 2024

Head to Head Review: Mangoceuticals (MGRX) versus Its Rivals - Defense World

Oct 23, 2024
pulisher
Oct 23, 2024

Mangoceuticals (MGRX) versus Its Rivals Head to Head Review - Defense World

Oct 23, 2024
pulisher
Oct 22, 2024

Mangoceuticals explores strategic alternatives to boost shareholder value By Investing.com - Investing.com Australia

Oct 22, 2024
pulisher
Oct 22, 2024

Mangoceuticals explores strategic alternatives to boost shareholder value - Investing.com

Oct 22, 2024
pulisher
Oct 22, 2024

MangoRx Announces Formation of Strategy and Alternatives Committee - GlobeNewswire

Oct 22, 2024
pulisher
Oct 21, 2024

Mangoceuticals refutes claims made by Lilly in weight-loss drug lawsuit - MSN

Oct 21, 2024
pulisher
Oct 21, 2024

Mangoceuticals refutes claims made by Lilly in weight-loss drug lawsuit (NASDAQ:MGRX) - Seeking Alpha

Oct 21, 2024
pulisher
Oct 21, 2024

Mangoceuticals Board Initiates Process to Evaluate Strategic Alternatives - Marketscreener.com

Oct 21, 2024
pulisher
Oct 21, 2024

Mangoceuticals Defends Against Eli Lilly Allegations - TipRanks

Oct 21, 2024
pulisher
Oct 21, 2024

MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly - ForexTV.com

Oct 21, 2024
pulisher
Oct 21, 2024

MangoRx faces lawsuit from Eli Lilly over medication - Investing.com

Oct 21, 2024
pulisher
Oct 21, 2024

Mangoceuticals ‘refutes’ claims by Eli Lilly regarding sale of tirzepatide - TipRanks

Oct 21, 2024
pulisher
Oct 21, 2024

MangoRx faces lawsuit from Eli Lilly over medication By Investing.com - Investing.com UK

Oct 21, 2024
pulisher
Oct 21, 2024

Critical Contrast: Mangoceuticals (MGRX) and Its Rivals - Defense World

Oct 21, 2024
pulisher
Oct 21, 2024

Analyzing Mangoceuticals (MGRX) & Its Rivals - Defense World

Oct 21, 2024
pulisher
Oct 20, 2024

Reviewing Mangoceuticals (MGRX) and Its Competitors - Defense World

Oct 20, 2024
pulisher
Oct 19, 2024

Head-To-Head Contrast: Mangoceuticals (MGRX) vs. Its Peers - Defense World

Oct 19, 2024
pulisher
Oct 19, 2024

Mangoceuticals (MGRX) and Its Competitors Head-To-Head Review - Defense World

Oct 19, 2024
pulisher
Oct 19, 2024

Mangoceuticals (MGRX) and The Competition Critical Contrast - Defense World

Oct 19, 2024
pulisher
Oct 18, 2024

Mangoceuticals, Inc. Announces Participation at the Centurion One Capital 2nd Annual Bahamas Summit 2024 - Wetaskiwin Times Advertiser

Oct 18, 2024
pulisher
Oct 18, 2024

Mangoceuticals (MGRX) versus Its Competitors Financial Contrast - Defense World

Oct 18, 2024
pulisher
Oct 17, 2024

Mangoceuticals, Inc. announced that it has received $0.15 million in funding - Marketscreener.com

Oct 17, 2024
pulisher
Oct 17, 2024

Top 3 Risk Off Stocks Which Could Rescue Your Portfolio This Quarter - Benzinga

Oct 17, 2024
pulisher
Oct 17, 2024

Contrasting Mangoceuticals (MGRX) and Its Competitors - Defense World

Oct 17, 2024
pulisher
Oct 16, 2024

Head-To-Head Comparison: Mangoceuticals (MGRX) & The Competition - Defense World

Oct 16, 2024
pulisher
Oct 15, 2024

Examining Mangoceuticals Inc (MGRX) more closely is necessary - US Post News

Oct 15, 2024
pulisher
Oct 14, 2024

Mangoceuticals Inc (MGRX) Stock: A Year of Declines and Increases - The InvestChronicle

Oct 14, 2024
pulisher
Oct 14, 2024

Upward Trajectory: Mangoceuticals Inc (MGRX) Posts a Slidee, Closing at 0.21 - The Dwinnex

Oct 14, 2024
$19.22
price up icon 1.21%
health_information_services EVH
$23.36
price down icon 0.43%
$16.81
price down icon 2.55%
health_information_services WAY
$28.65
price down icon 0.42%
health_information_services RCM
$14.28
price up icon 0.14%
health_information_services HQY
$86.95
price up icon 0.72%
Kapitalisierung:     |  Volumen (24h):